AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16760859 — intervention group
Group type: EXPERIMENTAL
Intervention: Powerlink Bifurcated endovascular graft
Number of subjects: 258
Study 16760859 — intervention group
Group type: COMPARATOR
Intervention: Control (open AAA repair)
Number of subjects: 258
Study 16433156 — intervention group
Group type: EXPERIMENTAL
Intervention: Microsurgery (laparotomy)
Number of subjects: 224
Study 16433156 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopy
Number of subjects: 224
Study 12039422 — intervention group
Group type: EXPERIMENTAL
Intervention: Riluzole 50mg capsules orally, taken twice daily
Number of subjects: 20
Study 12039422 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 12039422 — intervention group
Group type: EXPERIMENTAL
Intervention: Riluzole
Number of subjects: 20
Study 10213062 — intervention group
Group type: EXPERIMENTAL
Intervention: Transversely split velum (TS) flaps
Number of subjects: 42
Study 10213062 — intervention group
Group type: COMPARATOR
Intervention: Midline split (MS) flaps
Number of subjects: 42
Study 7781667 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin treatment in 108 NIDDM patients with Lp(a) concentration < 300 mgL-1
Number of subjects: 145
Study 7781667 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin treatment in subjects with elevated Lp(a) concentrations (> 300 mgL-1)
Number of subjects: 145
Study 7781667 — intervention group
Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 145
Study 2202462 — intervention group
Group type: EXPERIMENTAL
Intervention: Total body irradiation followed by 12 courses of high dose cytosine arabinoside (Ara‐C)
Number of subjects: 68
Study 2202462 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide-containing preparative regimens
Number of subjects: 68
Study 38705 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dose of 10 mg of metopimazine, three times D-1, for two days
Number of subjects: 84
Study 38705 — intervention group
Group type: COMPARATOR
Intervention: Identically administered placebo
Number of subjects: 84
Study 31009289 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 2 mg tolterodine and 9 mg pilocarpine
Number of subjects: 100
Study 31009289 — intervention group
Group type: COMPARATOR
Intervention: Tolterodine monotherapy (2 mg twice daily)
Number of subjects: 100
Study 27761943 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptive working memory training (WMT)
Number of subjects: 201
Study 27761943 — intervention group
Group type: COMPARATOR
Intervention: Nonadaptive working memory training (WMT)
Number of subjects: 201
Study 25974830 — intervention group
Group type: EXPERIMENTAL
Intervention: CO2 laser treatment
Number of subjects: 73
Study 25974830 — intervention group
Group type: COMPARATOR
Intervention: Traditional scalpel with electric knife (Control)
Number of subjects: 73
Study 23369444 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone-tendon Achilles allograft (group I)
Number of subjects: 72
Study 23369444 — intervention group
Group type: COMPARATOR
Intervention: Free tendon Achilles allograft (group II)
Number of subjects: 72
Study 20526626 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-site laparoscopic appendectomy (SSLA)
Number of subjects: 43
Study 20526626 — intervention group
Group type: COMPARATOR
Intervention: Conventional laparoscopic appendectomy (CLA)
Number of subjects: 43
Study 19144985 — intervention group
Group type: EXPERIMENTAL
Intervention: R-CHOP-14 (Rituximab with CHOP-14)
Number of subjects: 1222
Study 19144985 — intervention group
Group type: COMPARATOR
Intervention: CHOP-14
Number of subjects: 1222
Study 19144985 — intervention group
Group type: EXPERIMENTAL
Intervention: R-CHOP-14
Number of subjects: 1222
Study 19144985 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal methotrexate
Number of subjects: 1222
Study 17708384 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey dressings
Number of subjects: 40
Study 17708384 — intervention group
Group type: COMPARATOR
Intervention: Sugar dressings
Number of subjects: 40
Study 14982719 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 171
Study 14982719 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial activity
Number of subjects: 171
Study 14982719 — intervention group
Group type: EXPERIMENTAL
Intervention: Interaction between physical and psychosocial activity
Number of subjects: 171
Study 11480800 — intervention group
Group type: EXPERIMENTAL
Intervention: Foils selected based on their match to the perpetrator in perp-absent lineups
Number of subjects: 0
Study 11480800 — intervention group
Group type: COMPARATOR
Intervention: Foils selected based on their match to the innocent suspect in perp-absent lineups
Number of subjects: 0
Study 9972071 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with neurological disorders (mean blood lead levels 19.30 +/- 17.65 micrograms/dl)
Number of subjects: 82
Study 9972071 — intervention group
Group type: COMPARATOR
Intervention: Control children (mean blood lead levels 11.96 +/- 10.97 micrograms/dl)
Number of subjects: 82
Study 9972071 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with pica behaviour
Number of subjects: 82
Study 7735156 — intervention group
Group type: EXPERIMENTAL
Intervention: Low stimulus levels (L1 = 55, L2 = 40 dB SPL) in healthy term infants
Number of subjects: 50
Study 7735156 — intervention group
Group type: COMPARATOR
Intervention: Low stimulus levels (L1 = 55, L2 = 40 dB SPL) in healthy adults
Number of subjects: 50
Study 3189422 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine
Number of subjects: 34
Study 3189422 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 31327203 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro cultured Calculus Bovis
Number of subjects: 80
Study 30341276 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure-based cognitive behaviour therapy (CBT) for anxiety disorders, 4 weekly sessions
Number of subjects: 28
Study 30341276 — intervention group
Group type: COMPARATOR
Intervention: Waiting group (control)
Number of subjects: 28
Study 30341276 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure-based cognitive behaviour therapy (CBT)
Number of subjects: 28
Study 27875537 — intervention group
Group type: EXPERIMENTAL
Intervention: L-tryptophan (0.52 g and 1.56 g)
Number of subjects: 20
Study 27875537 — intervention group
Group type: EXPERIMENTAL
Intervention: L-tryptophan (1.56 g)
Number of subjects: 20
Study 27875537 — intervention group
Group type: EXPERIMENTAL
Intervention: L-tryptophan and L-leucine
Number of subjects: 20
Study 27875537 — intervention group
Group type: COMPARATOR
Intervention: Control (75 g glucose and 300 mL tap water)
Number of subjects: 20
Study 25005196 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified PCIOL implantation with transscleral fixation (39.95 ± 5.87 min)
Number of subjects: 82
Study 25005196 — intervention group
Group type: COMPARATOR
Intervention: Conventional PCIOL implantation in the ciliary sulcus (45.77 ± 5.21 min)
Number of subjects: 82
Study 25005196 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (modified and conventional)
Number of subjects: 82
Study 25005196 — intervention group
Group type: COMPARATOR
Intervention: Conventional group
Number of subjects: 82
Study 23258283 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI) intervention
Number of subjects: 63
Study 23258283 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 63
Study 20369718 — intervention group
Group type: EXPERIMENTAL
Intervention: dichlorobis (N1‐dichloromethyl‐3,5‐dimethylpyrazole, copper (II) compound
Number of subjects: 25
Study 20369718 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment with the copper (II) compound)
Number of subjects: 25
Study 17395047 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan (titrated to 32 mg once per day)
Number of subjects: 80
Study 17395047 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 15620485 — intervention group
Group type: EXPERIMENTAL
Intervention: Avanta implants
Number of subjects: 30
Study 15620485 — intervention group
Group type: COMPARATOR
Intervention: Swanson implants
Number of subjects: 30
Study 11832876 — intervention group
Group type: EXPERIMENTAL
Intervention: Gymnasts
Number of subjects: 12
Study 11832876 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 12
Study 10100393 — intervention group
Group type: EXPERIMENTAL
Intervention: Attentional selection based on spatial frequency
Number of subjects: 0
Study 10100393 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedural differences in studies
Number of subjects: 0
Study 10100393 — intervention group
Group type: COMPARATOR
Intervention: Contrast balancing
Number of subjects: 0
Study 8585113 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoclonal fluorescence polarization immunoassay (mFPIA) for cyclosporine monitoring in SPK recipients
Number of subjects: 12
Study 8585113 — intervention group
Group type: EXPERIMENTAL
Intervention: High-performance liquid chromatography (HPLC) for cyclosporine monitoring in SPK recipients
Number of subjects: 12
Study 8585113 — intervention group
Group type: COMPARATOR
Intervention: Monoclonal fluorescence polarization immunoassay (mFPIA) for cyclosporine monitoring in kidney-alone recipients
Number of subjects: 12
Study 2331636 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented visual feedback on magnitude of force application and cadence
Number of subjects: 6
Study 2331636 — intervention group
Group type: COMPARATOR
Intervention: Augmented feedback on pedaling rate
Number of subjects: 6
Study 375958 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg
Number of subjects: 15
Study 375958 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone 25 mg
Number of subjects: 15
Study 375958 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of Atenolol and Chlorthalidone
Number of subjects: 15
Study 375958 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 375958 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy vs Placebo
Number of subjects: 15
Study 31035784 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous Oxide (N2O) anesthesia
Number of subjects: 88
Study 31035784 — intervention group
Group type: COMPARATOR
Intervention: No Nitrous Oxide anesthesia
Number of subjects: 88
Study 31035784 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 88
Study 29329168 — intervention group
Group type: EXPERIMENTAL
Intervention: MenABCWY booster dose
Number of subjects: 190
Study 29329168 — intervention group
Group type: EXPERIMENTAL
Intervention: 4CMenB
Number of subjects: 190
Study 29329168 — intervention group
Group type: EXPERIMENTAL
Intervention: MenACWY-CRM
Number of subjects: 190
Study 29329168 — intervention group
Group type: EXPERIMENTAL
Intervention: MenABCWY and 4CMenB
Number of subjects: 190
Study 29329168 — intervention group
Group type: COMPARATOR
Intervention: MenABCWY
Number of subjects: 190
Study 27749572 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model for diabetes using a subdistribution hazards model
Number of subjects: 1857
Study 27749572 — intervention group
Group type: EXPERIMENTAL
Intervention: Body mass index, FPG, self‐rated health status, and physical activity
Number of subjects: 1857
Study 27749572 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor self‐rated health status
Number of subjects: 1857
Study 27749572 — intervention group
Group type: EXPERIMENTAL
Intervention: Less physical activity
Number of subjects: 1857
Study 27749572 — intervention group
Group type: EXPERIMENTAL
Intervention: Age 55-65 years
Number of subjects: 1857
Study 27749572 — intervention group
Group type: EXPERIMENTAL
Intervention: Overweight
Number of subjects: 1857
Study 27749572 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 1857
Study 27749572 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired fasting glucose (IFG)
Number of subjects: 1857
Study 27749572 — intervention group
Group type: EXPERIMENTAL
Intervention: Prediction model performance
Number of subjects: 1857
Study 24139668 — intervention group
Group type: EXPERIMENTAL
Intervention: Guided Experiential Learning (GEL)
Number of subjects: 30
Study 24139668 — intervention group
Group type: COMPARATOR
Intervention: Experiential Learning Theory (ELT)
Number of subjects: 30
Study 22311059 — intervention group
Group type: EXPERIMENTAL
Intervention: Active TENS
Number of subjects: 2
Study 22311059 — intervention group
Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 2
Study 19428117 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 x 90 minute psychoeducation sessions (SIMSEP)
Number of subjects: 58
Study 19428117 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 58
Study 19428117 — intervention group
Group type: EXPERIMENTAL
Intervention: SIMSEP
Number of subjects: 58
Study 19428117 — intervention group
Group type: COMPARATOR
Intervention: TAU
Number of subjects: 58
Study 17599429 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention strategies from the ACCORD trial
Number of subjects: 4311
Study 17599429 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis (CEA)
Number of subjects: 4311
Study 17599429 — intervention group
Group type: EXPERIMENTAL
Intervention: Health Utilities Index Mark 3 (HUI-3)
Number of subjects: 4311
Study 17599429 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct medical costs
Number of subjects: 4311
Study 17599429 — intervention group
Group type: EXPERIMENTAL
Intervention: HRQOL assessments
Number of subjects: 4311
Study 15958322 — intervention group
Group type: COMPARATOR
Intervention: Conventional radiotherapy (66 to 70 Gy in 33 to 35 fractions over 6 to 7 weeks)
Number of subjects: 86
Study 15958322 — intervention group
Group type: EXPERIMENTAL
Intervention: Late course 3DCRT (24-30 Gy in 6 fractions, 400-500 cGy per fraction every other day after 40 Gy conventional radiotherapy, completed in 5 to 6 weeks)
Number of subjects: 86
Study 11851644 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NMMA (NO synthase inhibitor)
Number of subjects: 8
Study 11851644 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 8
Study 11851644 — intervention group
Group type: EXPERIMENTAL
Intervention: ANGII
Number of subjects: 8
Study 11155471 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (LC)
Number of subjects: 18
Study 11155471 — intervention group
Group type: COMPARATOR
Intervention: Open cholecystectomy (OC)
Number of subjects: 18
Study 8636779 — intervention group
Group type: EXPERIMENTAL
Intervention: GM‐CSF 5 micrograms/kg/d
Number of subjects: 134
Study 8636779 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study 8636779 — intervention group
Group type: EXPERIMENTAL
Intervention: GM‐CSF
Number of subjects: 134
Study 1583243 — intervention group
Group type: EXPERIMENTAL
Intervention: Antigen challenge
Number of subjects: 6
Study 1583243 — intervention group
Group type: COMPARATOR
Intervention: Diluent control
Number of subjects: 6
Study 1583243 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with histamine and eosinophil influx
Number of subjects: 6
Study 1583243 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with area of late-phase response (LPR)
Number of subjects: 6
Study 6367882 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-operative radiotherapy (routine dose)
Number of subjects: 0
Study 6367882 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher dosage (more than 1510 ret)
Number of subjects: 0
Study 6367882 — intervention group
Group type: COMPARATOR
Intervention: Control group (no irradiation)
Number of subjects: 0
Study 6367882 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased radiotherapy dosage
Number of subjects: 0
Study 6367882 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiation
Number of subjects: 0
Study 31000783 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolic gastric bypass
Number of subjects: 40
Study 31000783 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeve gastrectomy
Number of subjects: 40
Study 31000783 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater curvature plication
Number of subjects: 40
Study 30053018 — intervention group
Group type: EXPERIMENTAL
Intervention: CPE isolates identified from rectal swabs
Number of subjects: 162
Study 30053018 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbapenemase characterization and antibiotic susceptibility testing
Number of subjects: 162
Study 30053018 — intervention group
Group type: EXPERIMENTAL
Intervention: Identification of carbapenemases
Number of subjects: 162
Study 30053018 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonality and diversity assessment
Number of subjects: 162
Study 30053018 — intervention group
Group type: EXPERIMENTAL
Intervention: Emergence of new clones
Number of subjects: 162
Study 27207971 — intervention group
Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 21105
Study 27207971 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 21105
Study 24549966 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive plate osteosynthesis (group A)
Number of subjects: 137
Study 24549966 — intervention group
Group type: EXPERIMENTAL
Intervention: Locking intramedullary nail (group B)
Number of subjects: 137
Study 24549966 — intervention group
Group type: EXPERIMENTAL
Intervention: External fixation combined with limited open reduction and absorbable internal fixation (group C)
Number of subjects: 137
Study 24549966 — intervention group
Group type: COMPARATOR
Intervention: All groups (A, B, C)
Number of subjects: 137
Study 21632443 — intervention group
Group type: EXPERIMENTAL
Intervention: NEPP
Number of subjects: 50
Study 21632443 — intervention group
Group type: COMPARATOR
Intervention: sPD
Number of subjects: 50
Study 21084546 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydro Acoustic Therapy (HAT)
Number of subjects: 18
Study 21084546 — intervention group
Group type: COMPARATOR
Intervention: flutter valve
Number of subjects: 18
Study 21084546 — intervention group
Group type: COMPARATOR
Intervention: placebo (sitting in the bath with sounds without vibration)
Number of subjects: 18
Study 18936373 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusive dressings (foams, alginates, hydrogels, hydrocolloids, hydrofibers, or films)
Number of subjects: 285
Study 18936373 — intervention group
Group type: COMPARATOR
Intervention: Gauze-based dressings
Number of subjects: 285
Study 18936373 — intervention group
Group type: EXPERIMENTAL
Intervention: Occlusive dressings
Number of subjects: 285
Study 15805860 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy
Number of subjects: 97
Study 15805860 — intervention group
Group type: COMPARATOR
Intervention: Control (ND before adjuvant therapy)
Number of subjects: 97
Study 15805860 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy alone
Number of subjects: 97
Study 12532470 — intervention group
Group type: EXPERIMENTAL
Intervention: Short veno-venous hemofiltration (SVVH)
Number of subjects: 36
Study 12532470 — intervention group
Group type: COMPARATOR
Intervention: Long veno-venous hemofiltration (LVVH)
Number of subjects: 36
Study 10756363 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin (high dose)
Number of subjects: 53
Study 10756363 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin (pump-prime-only dose)
Number of subjects: 53
Study 10756363 — intervention group
Group type: COMPARATOR
Intervention: No aprotinin treatment (control)
Number of subjects: 53
Study 8882473 — intervention group
Group type: COMPARATOR
Intervention: Supine bicycle exercise (SBE) in healthy controls
Number of subjects: 38
Study 8882473 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine bicycle exercise (SBE) in nephrotic syndrome patients
Number of subjects: 38
Study 8882473 — intervention group
Group type: COMPARATOR
Intervention: Comparison of ANP change between controls and nephrotic syndrome patients
Number of subjects: 38
Study 1645086 — intervention group
Group type: EXPERIMENTAL
Intervention: Low tar, middle nicotine cigarettes
Number of subjects: 643
Study 1645086 — intervention group
Group type: EXPERIMENTAL
Intervention: Middle tar, middle nicotine cigarettes
Number of subjects: 643
Study 1645086 — intervention group
Group type: EXPERIMENTAL
Intervention: Low tar, low nicotine cigarettes
Number of subjects: 643
Study 1645086 — intervention group
Group type: COMPARATOR
Intervention: Health warning (control group)
Number of subjects: 643
Study 31124600 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative antibiotic prophylaxis (PAP)
Number of subjects: 78
Study 31124600 — intervention group
Group type: EXPERIMENTAL
Intervention: PAP for immunocompromised patients
Number of subjects: 78
Study 31124600 — intervention group
Group type: EXPERIMENTAL
Intervention: Administration of PAP parenterally
Number of subjects: 78
Study 31124600 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalosporin cefuroxime
Number of subjects: 78
Study 31124600 — intervention group
Group type: EXPERIMENTAL
Intervention: Duration of PAP
Number of subjects: 78
Study 29186175 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vocabulary training program (definition method)
Number of subjects: 100
Study 29186175 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral vocabulary training program (context method)
Number of subjects: 100
Study 29186175 — intervention group
Group type: COMPARATOR
Intervention: Read-aloud method (control)
Number of subjects: 100
Study 26109246 — intervention group
Group type: EXPERIMENTAL
Intervention: High risk ASD group (36-month-olds)
Number of subjects: 0
Study 26109246 — intervention group
Group type: COMPARATOR
Intervention: Low risk control group (18- and 24-month-olds)
Number of subjects: 0
Study 26109246 — intervention group
Group type: EXPERIMENTAL
Intervention: High risk ASD group
Number of subjects: 0
Study 22576127 — intervention group
Group type: EXPERIMENTAL
Intervention: Condom use during sex acts
Number of subjects: 3257
Study 22576127 — intervention group
Group type: EXPERIMENTAL
Intervention: Situational factors related to male clients' behaviors
Number of subjects: 3257
Study 22576127 — intervention group
Group type: EXPERIMENTAL
Intervention: Having vaginal and anal sex at the same encounter
Number of subjects: 3257
Study 22576127 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of poor-fitting condoms
Number of subjects: 3257
Study 22576127 — intervention group
Group type: EXPERIMENTAL
Intervention: High client volume of FSWs
Number of subjects: 3257
Study 20922772 — intervention group
Group type: EXPERIMENTAL
Intervention: Psycho-educational programme (PEP) for primary caregivers in 12 group sessions for 3 months
Number of subjects: 167